Kipanib
THERAPEUTIC AREA: Oncology
ACTIVE PRINCIPLE: Pazopanib
PRESENTATION: 400mg x 30 coated tablets or 200 mg x 30
INDICATION:
- Renal Cell Caricinoma
- Soft Tissue Sarcoma
COUNTRIES WHERE IT IS MARKETED:
